Examines the process of introducing new cancer treatments into clinical practice and the complex problems that need to be faced, not only technically but also ethically, legally and politically. Areas covered are: ethics and consent, clinical trials, industry and cost of treatment development, treatment of premalignant lesions and cancer chemoprevention, reporting and choosing new treatments.
Be the first to review this book!
Discover more books in the same category